These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 2962716)
21. [Progress, failures and complications of hormonal drug therapy of patients with lingering rheumatism]. Mikhnev AL; Karapata AP Ter Arkh; 1969 Mar; 41(3):32-6. PubMed ID: 5307952 [No Abstract] [Full Text] [Related]
22. [Glucocorticoids in the therapy of rheumatism. 2: Systemic corticoid therapy]. Kaiser H Fortschr Med; 1998 Dec; 116(34):41-3. PubMed ID: 10024761 [No Abstract] [Full Text] [Related]
26. [ACTH or glucocorticoids]. Sterkowicz S Wiad Lek; 1970 Oct; 23(20):1777-83. PubMed ID: 4320526 [No Abstract] [Full Text] [Related]
27. [Osteoporosis in rheumatic diseases: role of glucocrticoids (part I)]. Nasonov EL; Skripnikova IA Klin Med (Mosk); 1997; 75(10):12-8. PubMed ID: 9490330 [No Abstract] [Full Text] [Related]
28. Anesthesia and postanesthetic considerations. Jackson S; Singleton M; Silcox D; Jackson E Clin Podiatr Med Surg; 1988 Jan; 5(1):169-92. PubMed ID: 2962718 [TBL] [Abstract][Full Text] [Related]
29. Macrophage activation syndrome: a frequent but under-diagnosed complication associated with rheumatic diseases. Tristano AG Med Sci Monit; 2008 Mar; 14(3):RA27-36. PubMed ID: 18301366 [TBL] [Abstract][Full Text] [Related]
31. Glucocorticoids in the treatment of rheumatic diseases: an update on the mechanisms of action. Buttgereit F; Straub RH; Wehling M; Burmester GR Arthritis Rheum; 2004 Nov; 50(11):3408-17. PubMed ID: 15529366 [No Abstract] [Full Text] [Related]
32. Principles of managing chronic rheumatic diseases. Vykydal M; Lindusková M Acta Univ Palacki Olomuc Fac Med; 1990; 125():133-40. PubMed ID: 2150268 [TBL] [Abstract][Full Text] [Related]
33. The epidemiology of glucocorticoid-associated adverse events. McDonough AK; Curtis JR; Saag KG Curr Opin Rheumatol; 2008 Mar; 20(2):131-7. PubMed ID: 18349741 [TBL] [Abstract][Full Text] [Related]
34. [Local injections of enzyme inhibitors in the treatment of rheumatic diseases]. Jacquot F; Riffat G; Verdier JM; Mouries D Rhumatologie; 1971; 23(6):219-24. PubMed ID: 5314976 [No Abstract] [Full Text] [Related]
35. A trial of an antirheumatic cream. Bisley BL; Lask A; Mendel D; Shepherd FS Br J Clin Pract; 1972 Oct; 26(10):477-9. PubMed ID: 4263692 [No Abstract] [Full Text] [Related]
36. [Corticosteroids in the treatment of rheumatic diseases]. AlusĂk S Vnitr Lek; 2000 Apr; 46(4):240-2. PubMed ID: 11227178 [TBL] [Abstract][Full Text] [Related]
37. Management of the podiatric surgical patient with systemic conditions. Tomczak RL Clin Podiatry; 1985 Oct; 2(4):693-705. PubMed ID: 2866857 [TBL] [Abstract][Full Text] [Related]
38. [Dietary therapy for inflammatory rheumatic diseases]. Adam O Dtsch Med Wochenschr; 2009 Sep; 134(36):1759-63. PubMed ID: 19718597 [TBL] [Abstract][Full Text] [Related]
39. [Infectious complications during the treatment of rheumatic diseases with glucocorticoids]. Novikov IuI; Chipigina NS Revmatologiia (Mosk); 1984; (3):45-51. PubMed ID: 6390631 [No Abstract] [Full Text] [Related]
40. [Pay attention to glucocorticoid-induced osteoporosis in treatment of rheumatic diseases]. Zhang X Zhonghua Nei Ke Za Zhi; 2008 May; 47(5):357-8. PubMed ID: 18953939 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]